Literature DB >> 18768158

Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease.

Susan Pyne1, Sue Chin Lee, Jaclyn Long, Nigel J Pyne.   

Abstract

Sphingosine 1-phosphate (S1P) is a bioactive lipid that is produced by the sphingosine kinase-catalysed phosphorylation of sphingosine. S1P is an important regulator of cell function, mediating many of its effects through a family of five closely related G protein-coupled receptors (GPCR) termed S1P(1-5) which exhibit high affinity for S1P. These receptors function to relay the effects of extracellular S1P via well-defined signal transduction networks linked to the regulation of cell proliferation, survival, migration etc. Diverse agonists (e.g. cytokines) also activate sphingosine kinase and the resulting S1P formed may bind to specific undefined intracellular targets to elicit cellular responses. The purpose of this review is to discuss some of the spatial/temporal aspects of intracellular S1P signalling and to define the function of sphingosine kinases and lipid phosphate phosphatases (which catalyse dephosphorylation of S1P) in terms of their regulation of cell function. Finally, we survey the function of S1P in relation to disease, where the major challenge is to dissect the role of intracellular versus extracellular actions of S1P in terms of association with defined diseased phenotypes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768158     DOI: 10.1016/j.cellsig.2008.08.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  42 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions.

Authors:  Jean A Castillo-Badillo; Tzindilú Molina-Muñoz; M Teresa Romero-Ávila; Aleida Vázquez-Macías; Richard Rivera; Jerold Chun; J Adolfo García-Sáinz
Journal:  Biochim Biophys Acta       Date:  2011-10-13

3.  Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications.

Authors:  Andreas R Janecke; Ruijuan Xu; Elisabeth Steichen-Gersdorf; Siegfried Waldegger; Andreas Entenmann; Thomas Giner; Iris Krainer; Lukas A Huber; Michael W Hess; Yaacov Frishberg; Hila Barash; Shay Tzur; Nira Schreyer-Shafir; Rivka Sukenik-Halevy; Tania Zehavi; Annick Raas-Rothschild; Cungui Mao; Thomas Müller
Journal:  Hum Mutat       Date:  2017-03-06       Impact factor: 4.878

4.  MMP-2 expression by fibroblasts is suppressed by the myofibroblast phenotype.

Authors:  Eric W Howard; Beverly J Crider; Dawn L Updike; Elizabeth C Bullen; Eileen E Parks; Carol J Haaksma; David M Sherry; James J Tomasek
Journal:  Exp Cell Res       Date:  2012-03-17       Impact factor: 3.905

5.  Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells.

Authors:  Jamie Cantrell Stanford; Andrew J Morris; Manjula Sunkara; Gabriel J Popa; Kara L Larson; Sabire Özcan
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

6.  Knockdown of sphingosine kinase 1 inhibits the migration and invasion of human rheumatoid arthritis fibroblast-like synoviocytes by down-regulating the PI3K/AKT activation and MMP-2/9 production in vitro.

Authors:  Hongxia Yuan; Pingting Yang; Dun Zhou; Wei Gao; Zhenyu Qiu; Fang Fang; Shuang Ding; Weiguo Xiao
Journal:  Mol Biol Rep       Date:  2014-05-10       Impact factor: 2.316

Review 7.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

8.  The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia.

Authors:  Robert A McDonald; Susan Pyne; Nigel J Pyne; Anne Grant; Cherry L Wainwright; Roger M Wadsworth
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 9.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

Review 10.  Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.

Authors:  Panfeng Fu; David L Ebenezer; Alison W Ha; Vidyani Suryadevara; Anantha Harijith; Viswanathan Natarajan
Journal:  J Cell Biochem       Date:  2018-05-08       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.